WMED .33 x .37 WORLDWIDE MEDICAL CORP - Ships Significant Opening Orders for Nine New First
Check Test Items - Into 24 Cardinal Health National Distribution Centers
Servicing More - Than 20,000 Pharmacies
New York, New York, Jul 17, 2002 (Market News Publishing via COMTEX) -- Daniel
G. McGuire, president and CEO of Worldwide Medical Corp., (www.wwmed.com), the
exclusive marketer of First Check(R) branded home screening tests for drugs of
abuse, alcohol, cholesterol and colorectal disease announced that the company
has secured nine new First Check test items in 24 Cardinal Health distribution
centers across the United States.
First Check's FDA over-the-counter cleared cholesterol, colorectal and drugs of
abuse home screening tests are now available to more than 20,000 drug and
supermarket pharmacies in the United States. Additionally, its Department of
Transportation-approved First Check CA 2000 alcohol detector is now also
available.
Cardinal Health is a leading provider of products and services supporting the
health-care industry. Cardinal companies develop, manufacture, package and
market products for patient care, develop drug-delivery technologies, distribute
over-the-counter consumer products to retail pharmacy settings, and offer
consulting and other services that improve quality and efficiency in health
care.
Cardinal Health is listed # 23 on the 2002 Fortune 500 and # 33 on Business
Week's list of "50 Best Companies."
The company is aggressively pursuing new retail distribution agreements with
Cardinal's retail partners. This past weekend, the company attended Cardinal
Health's national trade selling show in Seattle.
At this show, Cardinal Health invited all of their key retail partners and
preferred vendors to one location for the purpose of growing their business.
Cardinal Health's national distribution network will deliver significant
incremental sales to WMED's 52-week go forward operating plan.
Forward-looking statements in this release are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. Investors
are cautioned that such forward-looking statements involve risk and
uncertainties, including, but not limited to, the results of research and
development efforts, the effect of the U.S. Food and Drug Administration and
other agencies, the impact of competitive products, access to capital, market
demand for the company's products, changes in trade practices and the risk of
trade practice litigation, technological changes, intellectual property rights,
and other risks detailed from time-to-time in the company's reports.
CONTACT: TEL: 949/598-8378 Daniel G. Mc Guire or Kevin Gadawski,
FAX: 949/598-8757 Worldwide Medical Corp., Lake Forest
MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041.
(C) 2002 Market News Publishing Inc.
-0-
KEYWORD: New York, New York
*** end of story *** |
